ReviewEMBO molecular medicine2026
Artificial intelligence-enabled electrocardiography from scientific research to clinical application.
Review in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Diagnostic Accuracy of Artificial Intelligence-Based Electrocardiography for the Detection of Heart Diseases: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial intelligence-based ECG as a triage tool for acute myocardial infarction: a diagnostic systematic review and meta-analysis.European heart journal. Digital health · 2026Review
- Advances in the Interpretation of the Electrocardiogram by Artificial Intelligence.Diagnostics (Basel, Switzerland) · 2026Review
- Bridging the gap from clinical to home ECG: quantifying and overcoming accuracy loss in AI-enabled single-lead ECG models.NPJ digital medicine · 2026Article
- Detecting Occlusion Myocardial Infarction with an AI-Powered ECG Model: A Retrospective Cohort Study.Journal of personalized medicine · 2026Article
- AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in cardiovascular diagnostics. This review highlights the transformative impact of AI on traditional ECG analysis, detailing how deep learning algorithms are overcoming the limitations of human interpretation and conventional diagnostic criteria. Historically, ECG interpretation has relied on well-established, physiologically-based criteria. The advancement of AI-ECG is marked by its capacity to process complex high-dimensional data directly from raw signals, revealing patterns often missed by conventional methods. Notably, AI models have identified signs of asymptomatic low ejection fraction and paroxysmal atrial fibrillation during normal sinus rhythm, enabling earlier clinical intervention. In addition to improved diagnostic utility, AI-ECG offers promising applications in risk stratification and community screening. Several randomized controlled trials (RCTs) have shown that integrating AI into clinical workflows not only reduces critical intervention times but also identifies patients at elevated risk of adverse outcomes. Future directions involve integrating additional clinical data sources, improving model interpretability through explainable AI, and developing unified platforms to manage outputs from multiple models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.